Prevalence of Nemathelminthes in Cart Pulling Camels

Background: Camels are multipurpose animals, raised for the source of animal protein and transportation. Pakistan is also a major camel raising country and its population is one million. Parasitic disease cause impaired camel production, although the camels are less affected by the parasites, but some helminths affect them.Methods: The present study aimed to determine camels’ gastrointestinal helminths (nemathelminthes) in Sakrand, Sindh. The study was carried out in a total 100 dromedaries. The samples were collected and processed through the direct smear and floatation techniques.Results: The overall data showed a high infestation of nemathelminthes (62%) with the presence of following parasites; Trichostrongylus, Moniezia, Ostertagia, Haemonchus, Marshallagia, Trichuris, Toxocara, Ascaria, Escaria.Conclusion: To conclude nemathelminthes are major problem in camels under traditional husbandry. Regarding the high prevalence of infection use of parasitic control programmes are essential to improve camel health and productivity because camels play an important role in human lives by helping in transportation, work and provide production

PREVALENCE OF TICKS IN BUFFALOES IN THE UPPER SINDH PAKISTAN

ABSTRACT Tick infestation is still a major economic dilemma for the dairy owners in Pakistan. The current study reports the prevalence and bionomics of tick in the areas of upper Sindh, Pakistan. The study was carried out to identify and to quantify variation in the prevalence of bovine tick infestation with respect to host (age and species) and area studied. Random sampling was used and 1600 samples of Kundi buffaloes from the different areas were selected from extensive management systems. Prevalence of bovine tick infestation did not differ signifi cantly (OR = 0.876; p>0.05) in Kundi (179/800; 24.75%) and Nili-Ravi buffaloes (172/800; 22.3%). Hyalomma was the major tick species (10.2%; 163/1600), followed by Rhipicephalus (5.6%; 99/1600). The prevalence of ticks in calves (< 1 year) was signifi cantly (p < 0.05) higher compare to the adult animals (1-2 years and > 2 year animals). However, the prevalence of tick infestation was not associated (p > 0.05) with the location of the district. Moreover, the results of the prevalence of the ticks in the studied area provide the better understanding for evolving the strategic and tactile control of ticks in local breeds of dairy animals in the Sindh province

Factors affecting wool quality and quantity in sheep

There are varieties of factors which can affect wool (macro and micro elements of wool) in sheep directly or indirectly. Genetic and environmental factors are major factors influencing wool quality and quantity. There are some bacterial, viral, fungal and espically parasitic diseases which also affect the wool. Other factors are exogenous chemicals, hormones, weather and photo period. In the present study, existing knowledge on the factors affecting wool were reviewed but there are gaps to conduct research on fundamental aspects of wool growth, which could have relevance to other areas of biology.Keywords: Wool quality, staple length, ultra high-sulphur proteins, fleec

Brain Infection by Hepatitis E Virus Probably via Damage of the Blood-Brain Barrier Due to Alterations of Tight Junction Proteins

Extrahepatic injury, particularly neurologic dysfunctions such as Guillain-Barré syndrome, neurologic amyotrophy, and encephalitis/meningoencephalitis/myositis were associated with HEV infection, which was supported by both clinical and laboratory studies. Thus, it is crucial to figure out how the virus invades into the central nervous system (CNS). In this study, CNS lesions were determined in rabbits and Mongolian gerbils inoculated with genotype 4 HEV. Junctional proteins were detected in HEV infected primary human brain microvascular cells (HBMVCs). Viral encephalitis associated perivascular cuffs of lymphocytes and microglial nodules were observed in HEV infected rabbits. Both positive- and negative-strand of HEV RNA was detected in brain and spinal cord in rabbits intraperitoneally infected with HEV at 28 dpi (days postinoculation), but not in rabbits gavaged with HEV. HEV ORF2 protein was further examined in both brain and spinal cord sections of infected rabbits, with positive signals located mainly in neural cells and perivascular areas. Ultrastructural study showed thickened and reduplicated basement membranes of capillary endothelium in HEV RNA positive brain tissues. In vitro study showed loss of tight junction proteins including Claudin5, Occludin, and ZO-1 (zonula occludens-1) in HBMVCs inoculated with HEV for 48 h. These findings indicated that disruption of the blood-brain barrier (BBB) might be potential mechanisms of HEV invasion into the CNS. It provides new insights to further study HEV associated neurologic disorders and will be helpful for seeking potential therapeutics for HEV infection in the future

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

Background: Tranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. We aimed to assess the effects of tranexamic acid in patients with gastrointestinal bleeding. Methods: We did an international, multicentre, randomised, placebo-controlled trial in 164 hospitals in 15 countries. Patients were enrolled if the responsible clinician was uncertain whether to use tranexamic acid, were aged above the minimum age considered an adult in their country (either aged 16 years and older or aged 18 years and older), and had significant (defined as at risk of bleeding to death) upper or lower gastrointestinal bleeding. Patients were randomly assigned by selection of a numbered treatment pack from a box containing eight packs that were identical apart from the pack number. Patients received either a loading dose of 1 g tranexamic acid, which was added to 100 mL infusion bag of 0·9% sodium chloride and infused by slow intravenous injection over 10 min, followed by a maintenance dose of 3 g tranexamic acid added to 1 L of any isotonic intravenous solution and infused at 125 mg/h for 24 h, or placebo (sodium chloride 0·9%). Patients, caregivers, and those assessing outcomes were masked to allocation. The primary outcome was death due to bleeding within 5 days of randomisation; analysis excluded patients who received neither dose of the allocated treatment and those for whom outcome data on death were unavailable. This trial was registered with Current Controlled Trials, ISRCTN11225767, and ClinicalTrials.gov, NCT01658124. Findings: Between July 4, 2013, and June 21, 2019, we randomly allocated 12 009 patients to receive tranexamic acid (5994, 49·9%) or matching placebo (6015, 50·1%), of whom 11 952 (99·5%) received the first dose of the allocated treatment. Death due to bleeding within 5 days of randomisation occurred in 222 (4%) of 5956 patients in the tranexamic acid group and in 226 (4%) of 5981 patients in the placebo group (risk ratio [RR] 0·99, 95% CI 0·82–1·18). Arterial thromboembolic events (myocardial infarction or stroke) were similar in the tranexamic acid group and placebo group (42 [0·7%] of 5952 vs 46 [0·8%] of 5977; 0·92; 0·60 to 1·39). Venous thromboembolic events (deep vein thrombosis or pulmonary embolism) were higher in tranexamic acid group than in the placebo group (48 [0·8%] of 5952 vs 26 [0·4%] of 5977; RR 1·85; 95% CI 1·15 to 2·98). Interpretation: We found that tranexamic acid did not reduce death from gastrointestinal bleeding. On the basis of our results, tranexamic acid should not be used for the treatment of gastrointestinal bleeding outside the context of a randomised trial

Detection and localization of rabbit hepatitis e virus and antigen in systemic tissues from experimentally intraperitoneally infected rabbits.

Rabbit hepatitis E virus (HEV) is a novel genotype of HEV, and is considered to pose a risk of zoonotic transmission. Research into the systemic distribution of rabbit HEV in rabbits during different periods of infection has rarely been reported. To better understand this virus, we infected rabbits with second-passage rabbit HEV via an intraperitoneal route. After inoculation, the infection showed two types, temporary and constant infection. The detection of HEV RNA in the feces varied with time, and serum antigen correlated with fecal HEV RNA. Viremia only appeared 72 days after inoculation. The rabbits remained antibody negative throughout the experimental period. When HEV was localized, several organs besides the liver were HEV RNA positive. Tissue antigen was observed immunohistochemically in the different cells of various organs, especially in parts of the small intestine and the characteristic rabbit gut-associated lymphoid tissue. These data provide valuable information for future research into the pathogenesis of HEV

Case Report Associated with Aspergillosis and Hepatitis E Virus Coinfection in Himalayan Griffons

This study involved a death which occurred in four Himalayan griffons housed in Beijing zoo, China. Based on pathogen identification and the pathological changes observed, we did characterize the fungi and Hepatitis E virus (HEV) in four dead Himalayan griffons. Pathological changes were severe. Membranous-like material was observed on the surface of the internal organs. Spleen was necrotic. Focal lymphocyte infiltration in the liver and many sunflower-like fungi nodules were evident in the tissues, especially in the kidney. PCR was used to identify the pathogen. Based on the 18SrRNA genomic sequence of known fungi, the results confirmed that all four dead Himalayan griffons were infected with Aspergillus. At the same time the detection of HEV also showed positive results. To the best of our knowledge, this work appears to be the first report of concurrent presence of Aspergillosis and Hepatitis E virus in rare avian species